PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22869640-6	2013	Postbout blood [La] suggests that boxers must be able to tolerate a lactate production rate of 1.8 mmol   L-1   min-1 and maintain skillful techniques at a sufficient activity rate.	Lactic Acid	68-75	immunoglobulin kappa variable 1-16	Homo sapiens	106-117	
30032876-7	2018	Lactate elevation (>4.0 mM L-1) was associated with 86.1% specificity and 67.8% positive predictive value for massive transfusion.	Lactic Acid	0-7	immunoglobulin kappa variable 1-16	Homo sapiens	30-33	
22857018-7	2012	The time taken to reach onset of blood lactate accumulation (OBLA, defined as the point where blood lactate reaches 4 mmol L-1) was significantly increased following 2 weeks of HIT (p = 0.003).	Lactic Acid	39-46	immunoglobulin kappa variable 1-16	Homo sapiens	123-126	
2229281-3	1990	In spite of this, in the diabetic patients lactate (5.1 +/- 0.8 mumol L-1 min-1) and alanine (2.6 +/- 0.4) release by the forearm was 3- and 2-fold higher than in the control group (lactate: 1.7 +/- 0.8, P less than 0.005; and alanine: 1.3 +/- 0.2, P less than 0.05, respectively).	Lactic Acid	43-50	immunoglobulin kappa variable 1-16	Homo sapiens	70-79	
32182930-7	2020	As a result of the experiments carried out, optimal conditions to remove suspended particles were set at a lactic acid concentration of 1.75 g L-1.	Lactic Acid	107-118	immunoglobulin kappa variable 1-16	Homo sapiens	143-146	
30098415-7	2019	The presence of lactic acid also substantially affected the removal of phosphate from RFB when 132 mg L-1 phosphate was initially present: after 120 min, only 28.6 mg L-1 of phosphate had been removed.	Lactic Acid	16-27	immunoglobulin kappa variable 1-16	Homo sapiens	102-105	
30098415-7	2019	The presence of lactic acid also substantially affected the removal of phosphate from RFB when 132 mg L-1 phosphate was initially present: after 120 min, only 28.6 mg L-1 of phosphate had been removed.	Lactic Acid	16-27	immunoglobulin kappa variable 1-16	Homo sapiens	167-170	
30032876-8	2018	When combining elevated lactate concentrations (>4.0 mM L-1) with a shock index >1.0, the specificity and positive predictive value increased to 95.5% and 82.4%, respectively.	Lactic Acid	24-31	immunoglobulin kappa variable 1-16	Homo sapiens	59-62	
28702085-5	2017	The lactic acid concentration was 9.36 +- 0.95 g L-1 over a 33-day semi-continuous operation, and converted to caproic acid at pH 5.5-6.2, with a concentration of 4.09 +- 0.54 g L-1 during stable production.	Lactic Acid	4-15	immunoglobulin kappa variable 1-16	Homo sapiens	49-52	
28702085-5	2017	The lactic acid concentration was 9.36 +- 0.95 g L-1 over a 33-day semi-continuous operation, and converted to caproic acid at pH 5.5-6.2, with a concentration of 4.09 +- 0.54 g L-1 during stable production.	Lactic Acid	4-15	immunoglobulin kappa variable 1-16	Homo sapiens	178-181	
28467384-2	2017	In batch fermentations, the bioconversion of glucose is strongly inhibited in the presence of more than 100 g L-1 lactic acid and is only possible when the product is simultaneously removed, which can be achieved by ceramic membrane filtration.	Lactic Acid	114-125	immunoglobulin kappa variable 1-16	Homo sapiens	110-113	
28467384-5	2017	Continuous fermentation under these conditions, thus, achieved a stable productivity of ~8 g L-1 h-1 and the concentration of lactic acid was maintained at ~40 g L-1 at a dilution rate of 0.2 h-1.	Lactic Acid	126-137	immunoglobulin kappa variable 1-16	Homo sapiens	162-165	
29195878-6	2016	The production and release of 2g L-1 of lactic acid was achieved through encapsulation of L. plantarum, after 20h.	Lactic Acid	40-51	immunoglobulin kappa variable 1-16	Homo sapiens	33-36